carbidopa, levodopa and entacapone NDC 46708-796

Product information

Brand name (proprietary)

carbidopa, levodopa and entacapone

Generic name (nonproprietary)

carbidopa, levodopa and entacapone

Active ingredients

Carbidopa — 18.75 mg/1Levodopa — 75 mg/1Entacapone — 200 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Alembic Pharmaceuticals Limited

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 218535

Marketing start

Feb 12, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Aromatic (Chemical structure)Catechol O-Methyltransferase Inhibitors (Mechanism)

Identifiers

Product ID 46708-796_9ff83838-b7d0-4eec-98f2-fcc85789a189SPL ID 9ff83838-b7d0-4eec-98f2-fcc85789a189SPL set ID 9ff83838-b7d0-4eec-98f2-fcc85789a189RxCUI 403850, 403851, 403852, 730988, 810083, 810090UNII 46627O600J, MNX7R8C5VO, 4975G9NM6TUPC 0346708797317, 0346708799311, 0346708800314, 0346708798314, 0346708796310, 0346708795313

Pharmacologic class

Aromatic Amino Acid; Catechol-O-Methyltransferase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446708079631 followed by a unit qualifier and the quantity Copy

Package 46708-0796-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 218535

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.